Text Size

Triclosan Coated Suture Wound Closure for Peripheral Vascular Surgery: a Prospective Multicenter Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sanna Kouhia, North Carelia Central Hospital
ClinicalTrials.gov Identifier:
NCT01101789
First received: April 8, 2010
Last updated: January 3, 2012
Last verified: January 2012
History of Changes
  Purpose

This is a prospective randomized multicenter study which purpose is to determine whether triclosan-coated sutures for wound closure after lower limb vascular surgery would reduce the incidence of surgical wound infections.


Condition Intervention
Surgical Wound Infection
 Procedure: triclosan coated suture for surgical wound closure

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Triclosan Coated Suture Wound Closure for Peripheral Vascular Surgery: a Prospective Multicenter Study

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by North Karelia Central Hospital:

Primary Outcome Measures:
  • surgical wound infection [ Time Frame: one month after surgical procedure ] [ Designated as safety issue: Yes ]

Enrollment: 276
Study Start Date: April 2010
Study Completion Date: January 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: triclosan coated suture for surgical wound closure
    triclosan coated suture for surgical wound closure
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patient undergoing peripheral vascular surgery procedure

Exclusion Criteria:

  • patients refusal
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01101789

Locations
Finland
North Carelia central hospital
Joensuu, Finland, 80210
Sponsors and Collaborators
North Karelia Central Hospital
Investigators
Study Director: Johanna Turtiainen, MD North Karelia Central Hospital
Principal Investigator: Kimmo Makinen Kuopio University Hospital
Principal Investigator: Maarit Venermo Helsinki University Central Hospital
Principal Investigator: Eija Saimanen South Carelia Central Hospital
Study Director: Ilkka Uurto Tampere University Hospital
  More Information

No publications provided

Responsible Party: Sanna Kouhia, MD, North Carelia Central Hospital
ClinicalTrials.gov Identifier: NCT01101789     History of Changes
Other Study ID Numbers: NKCH-surg-006
Study First Received: April 8, 2010
Last Updated: January 3, 2012
Health Authority: Finland: North Carelia central hospital, department of vascular surgery

Keywords provided by North Karelia Central Hospital:
surgical wound infection
triclosan-coated suture

Additional relevant MeSH terms:
Surgical Wound Infection
Wound Infection
Infection
Postoperative Complications
Pathologic Processes
Wounds and Injuries
Triclosan
Hexachlorophene
Fatty Acid Synthesis Inhibitors
 Hypolipidemic Agents
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Anti-Infective Agents, Local
Anti-Infective Agents
Therapeutic Uses
Lipid Regulating Agents

ClinicalTrials.gov processed this record on May 16, 2013